Literature DB >> 7590785

Mouse monoclonal antibodies to human immunodeficiency virus glycoprotein 120 generated by repeated immunization with glycoprotein 120 from a single isolate, or by sequential immunization with glycoprotein 120 from three isolates.

J P Reeves1, C Y Lo, D M Klinman, S L Epstein.   

Abstract

Mouse hybridomas were isolated that produce monoclonal antibodies (MAbs) to several regions of the HIV envelope, gp120, which may be used to map immunogenic regions in animal and human immunity. One series of MAbs was generated by repeated immunization with recombinant gp120 (rgp120) from a single isolate, and a second series by sequential immunization with rgp120 from three isolates. All MAbs bound to rgp120IIIB, but only one bound well to cell surface-expressed gp160. Synthetic peptides spanning much of the length of gp120 were used to map MAb reactivity. Two MAbs were mapped to the C1 region, one to the C2 region, and three to the C5 region by this approach. Six distinct epitopes were detected by competitive binding analysis. One MAb binding the C1 region blocks binding of CD4 to rgp120IIIB, binds by ELISA to rgp120MN (an isolate not used during immunization), and binds to cell surface-expressed gp160. These hybridomas will be made available to the scientific community through a hybridoma culture facility.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590785     DOI: 10.1089/hyb.1995.14.235

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  7 in total

1.  The aqueous phase of Alzheimer's disease brain contains assemblies built from ∼4 and ∼7 kDa Aβ species.

Authors:  Jessica M Mc Donald; Tiernan T O'Malley; Wen Liu; Alexandra J Mably; Gunnar Brinkmalm; Erik Portelius; William M Wittbold; Matthew P Frosch; Dominic M Walsh
Journal:  Alzheimers Dement       Date:  2015-04-04       Impact factor: 21.566

2.  Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau In Vivo.

Authors:  Tomas Ondrejcak; Igor Klyubin; Grant T Corbett; Graham Fraser; Wei Hong; Alexandra J Mably; Matthew Gardener; Jayne Hammersley; Michael S Perkinton; Andrew Billinton; Dominic M Walsh; Michael J Rowan
Journal:  J Neurosci       Date:  2018-10-24       Impact factor: 6.167

3.  Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.

Authors:  Alexandra J Mably; Wen Liu; Jessica M Mc Donald; Jean-Cosme Dodart; Frédérique Bard; Cynthia A Lemere; Brian O'Nuallain; Dominic M Walsh
Journal:  Neurobiol Dis       Date:  2015-07-26       Impact factor: 5.996

4.  Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins.

Authors:  Feng Gao; Richard M Scearce; S Munir Alam; Bhavna Hora; Shimao Xia; Julie E Hohm; Robert J Parks; Damon F Ogburn; Georgia D Tomaras; Emily Park; Woodrow E Lomas; Vernon C Maino; Susan A Fiscus; Myron S Cohen; M Anthony Moody; Beatrice H Hahn; Bette T Korber; Hua-Xin Liao; Barton F Haynes
Journal:  Virology       Date:  2009-09-09       Impact factor: 3.616

Review 5.  Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale.

Authors:  Jody D Berry
Journal:  Vet J       Date:  2005-09       Impact factor: 2.688

6.  IgG Conformer's Binding to Amyloidogenic Aggregates.

Authors:  Monichan Phay; Alfred T Welzel; Angela D Williams; Helen P McWilliams-Koeppen; Veronika Blinder; Tiernan T O'Malley; Alan Solomon; Dominic M Walsh; Brian O'Nuallain
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

7.  An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer's disease.

Authors:  Ming Jin; Brian O'Nuallain; Wei Hong; Justin Boyd; Valentina N Lagomarsino; Tiernan T O'Malley; Wen Liu; Charles R Vanderburg; Matthew P Frosch; Tracy Young-Pearse; Dennis J Selkoe; Dominic M Walsh
Journal:  Nat Commun       Date:  2018-07-11       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.